News

Heather Whitson’s new research into lucidity asks a profound question: if a dementia patient returns to clarity, were those capabilities ever truly gone?

A new study led by Duke/UNC ADRC Core Leader Andy Liu examined outcomes among 230 patients treated with lecanemab for early Alzheimer’s disease. The findings provide valuable real-world information about treatment safety, side effects, and patient monitoring as disease-modifying therapies become more widely available.

A long-term study of more than 12,000 adults found that people who maintained normal blood pressure, avoided diabetes, and did not smoke lived nearly 13 more years without dementia than those with all three risk factors. The findings support a growing body of evidence linking cardiovascular health to cognitive aging and dementia prevention.

A new American Geriatrics Society position statement provides guidance for the responsible use of generative AI in the care of older adults. The recommendations emphasize clinician oversight, transparency, patient-centered care, and careful evaluation of AI tools in aging populations, including people living with cognitive impairment and dementia. The framework aims to ensure that emerging technologies enhance, rather than replace, trusted clinical relationships and individualized care.

The Duke–UNC ADRC honored study participants at its 3rd Annual Appreciation Event, featuring research updates, inspiring speakers, and meaningful community connection.

Dr. Gwenn Garden, Center Co-Director, spoke with Spectrum News about the ADRC, Alzheimer’s Disease research, and early AD symptoms.